Shared Decision Making in Patients with Stable Coronary Artery Disease: PCI Choice

Background Percutaneous coronary intervention (PCI) and optimal medical therapy (OMT) are comparable, alternative therapies for many patients with stable angina; however, patients may have misconceptions regarding the impact of PCI on risk of death and myocardial infarction (MI) in stable coronary artery disease (CAD). Methods and Results We designed and developed a patient-centered decision aid (PCI Choice) to promote shared decision making for patients with stable CAD. The estimated benefits and risks of PCI+OMT as compared to OMT were displayed in a decision aid using pictographs with natural frequencies and text. We engaged patients, clinicians, health service researchers, and designers with over 20 successive iterations of the decision aid, which were field tested during real-world clinical encounters involving clinicians and patients. The decision aid is intended to facilitate knowledge transfer, deliberation based on patient values and preferences, and shared decision making. Conclusions We describe the methods and outcomes of the design and development of a decision aid (PCI Choice) to promote shared decision making between clinicians and patients regarding the choice of PCI+OMT vs. OMT for treatment of stable CAD. We will evaluate the impact of PCI Choice on patient knowledge, decisional conflict, participation in decision-making, and treatment choice in an upcoming randomized trial.

[1]  J. Blankenship.  Progress toward doing the right thing. , 2012, JACC. Cardiovascular interventions.

[2]  D. Kent,et al.  Personalizing evidence-based primary prevention with aspirin: individualized risks and patient preference. , 2011, Circulation. Cardiovascular quality and outcomes.

[3]  David L. Brown,et al.  Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. , 2012, Archives of internal medicine.

[4]  Alice Jacobs,et al.  Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions. , 2009, JACC. Cardiovascular interventions.

[5]  David M Nestler,et al.  The Chest Pain Choice trial: a pilot randomized trial of a decision aid for patients with chest pain in the emergency department , 2010, Trials.

[6]  V. Novack,et al.  Frequency and impact of bleeding in elective coronary stent clinical trials—Utility of three commonly used definitions , 2012, Catheterization and cardiovascular interventions.

[7]  Harlan M. Krumholz,et al.  Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement: Results From the PREMIER Registry , 2006, Circulation.

[8]  Maggie Breslin,et al.  The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes. , 2008, Patient education and counseling.

[9]  Rebecca L. Kesman,et al.  Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice , 2009, Trials.

[10]  Stanley E. Kaufman,et al.  Effect of PCI on quality of life in patients with stable coronary disease. , 2008, The New England journal of medicine.

[11]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[12]  D. Berman,et al.  Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[13]  E. Hess,et al.  SHARED DECISION-MAKING RESULTS IN KNOWLEDGE TRANSFER ACROSS DIVERSE PATIENT SUBGROUPS: AN ENCOUNTER-LEVEL META-ANALYSIS OF DECISION AID TRIALS , 2012 .

[14]  L. Wann,et al.  ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thor , 2012, Journal of the American College of Cardiology.

[15]  Ann Barry Flood,et al.  Modifying unwarranted variations in health care: shared decision making using patient decision aids. , 2004, Health affairs.

[16]  Rebecca L. Kesman,et al.  Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. , 2011, The American journal of medicine.

[17]  Aditi Saxena,et al.  The Emergency Department , 2010 .

[18]  H. Krumholz,et al.  Putting ad hoc PCI on pause. , 2010, JAMA.

[19]  J. Spertus,et al.  Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. , 2011, JAMA.

[20]  Gordon H Guyatt,et al.  The diabetes mellitus medication choice decision aid: a randomized trial. , 2009, Archives of internal medicine.

[21]  L. Shaw,et al.  ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[22]  Kevin Kennedy,et al.  Appropriateness of percutaneous coronary intervention. , 2011, JAMA.

[23]  Salomeh Keyhani,et al.  Overuse of health care services in the United States: an understudied problem. , 2012, Archives of internal medicine.

[24]  P. Fitzgerald,et al.  Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary , 2011, JACC. Cardiovascular interventions.

[25]  J. Spertus,et al.  Abstract 233: Patient Factors Minimally Impact Experience with Informed Consent Documents for Percutaneous Coronary Intervention , 2012, Circulation: Cardiovascular Quality and Outcomes.

[26]  P. Ubel,et al.  The impact of the format of graphical presentation on health-related knowledge and treatment choices. , 2008, Patient education and counseling.

[27]  Sheng-Chia Chung,et al.  Health Status After Treatment for Coronary Artery Disease and Type 2 Diabetes Mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial , 2010, Circulation.

[28]  Gerd Gigerenzer,et al.  Transparency in Risk Communication , 2008, Annals of the New York Academy of Sciences.

[29]  Maggie Breslin,et al.  Creating a Conversation: Insights from the Development of a Decision Aid , 2007, PLoS medicine.

[30]  Gabriel E. Soto,et al.  Converting the Informed Consent From a Perfunctory Process to an Evidence-Based Foundation for Patient Decision Making , 2008, Circulation. Cardiovascular quality and outcomes.

[31]  G. Levine,et al.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Journal of the American College of Cardiology.

[32]  J. Spertus,et al.  ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Th , 2009, Journal of the American College of Cardiology.

[33]  Irina Proskorovsky,et al.  Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention: Results From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction TRI , 2010, Circulation.

[34]  Mario J. Garcia,et al.  ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[35]  R. Blumenthal,et al.  Placing COURAGE in context: review of the recent literature on managing stable coronary artery disease. , 2008, Mayo Clinic proceedings.

[36]  P. Aylward,et al.  A randomised study of three different informational AIDS prior to coronary angiography, measuring patient recall, satisfaction and anxiety. , 2008, Heart, lung & circulation.

[37]  Y. Schenker,et al.  Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. , 2011, Annals of internal medicine.

[38]  Amiram Gafni,et al.  Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. , 2007, Archives of internal medicine.

[39]  D. Taggart,et al.  Informed consent for interventions in stable coronary artery disease: problems, etiologies, and solutions. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[40]  R. Henry,et al.  Nurse-Led Group Visits Support Shared Decision Making in Stable Coronary Artery Disease , 2013, The Journal of cardiovascular nursing.

[41]  Fredrik Folke,et al.  Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. , 2010, Archives of internal medicine.